1 The whole-cell patch-clamp was used for studying the eects of various b 1 -and b 2 -adrenoceptor agonists and antagonists on the L-type Ca current (I Ca ) in frog ventricular myocytes. 2 Dose-response curves for the eects of isoprenaline (non selective b-agonist), salbutamol (b 2 -agonist), dobutamine (b 1 -agonist) on I Ca were obtained in the absence and presence of various concentrations of ICI 118551 (b 2 -antagonist), metoprolol (b 1 -antagonist) and xamoterol (partial b 1 -agonist) to derive EC 50 (i.e. the concentration of b-agonist at which the response was 50% of the maximum) and E max (the maximal response) values by use of a Michaelis equation. Schild regression analysis was performed to examine whether the antagonists were competitive and to determine the equilibrium dissociation constant (K B ) for the antagonist-receptor complex. 3 Isoprenaline increased I Ca with an EC 50 of 20.0 nM and an E max of 597%. ICI 118551 and metoprolol competitively antagonized the eect of isoprenaline with a K B of 3.80 nM and 207 nM, respectively. 4 Salbutamol increased I Ca with an EC 50 of 290 nM and an E max of 512%. ICI 118551 and metoprolol competitively antagonized the eect of salbutamol with a K B of 1.77 nM and 456 nM, respectively. 5 Dobutamine increased I Ca with an EC 50 of 2.40 mM and an E max of 265%. ICI 118551 and metoprolol competitively antagonized the eect of dobutamine with a K B of 2.84 nM and 609 nM, respectively. 6 Xamoterol had no stimulating eect on I Ca . However, xamoterol competitively antagonized the stimulating eects of isoprenaline, salbutamol and dobutamine on I Ca with a K B of 58 ± 64 nM. 7 We conclude that a single population of receptors is involved in the b-adrenoceptor-mediated regulation of I Ca in frog ventricular myocytes. The pharmacological pattern of the response of I Ca to the dierent b-adrenoceptor agonists and antagonists tested suggests that these receptors are of the b 2 -subtype.
Introduction b 1 -and b 2 -adrenoceptors coexist in the heart of various animal species, including man. Both receptors are positively coupled to the adenylyl cyclase system and participate in the mediation of the positive chronotropic and inotropic eects of catecholamines (for reviews, see Stiles et al., 1984; Brodde, 1991) . However, the relative amount of each receptor subtype as well as the post-receptor cellular signalling pathways may dier signi®cantly depending on the cardiac tissue, the animal species, the pathophysiological state, the age or the developmental stage (for reviews, see Stiles et al., 1984; Brodde, 1991; Hieble & Ruolo, 1991 and references therein) . Competitive radioligand binding studies performed in membranes from homogenized hearts have shown that only 20 ± 30% of the total b-adrenoceptors are of the b 2 -subtype in adult mammalian ventricular tissue (Stiles et al., 1984; Brodde, 1991; Hieble & Ruolo, 1991) . This number is even further reduced when puri®ed cardiac myocytes rather than homogenized tissues are used (Lau et al., 1980; Buxton & Brunton, 1985; Freissmuth et al., 1986; Kuznetsov et al., 1995; Cerbai et al., 1995) . Yet, selective activation of b 2 -adrenoceptors produces a large increase in the amplitude of contraction in intact mammalian cardiac muscle (Cerbai et al., 1990; Lemoine & Kaumann, 1991; Brodde, 1991) as well as in isolated ventricular myocytes (del Monte et al., 1993; Xiao & Lakatta, 1993; Xiao et al., 1994; Altschuld et al., 1995; Kuznetsov et al., 1995) .
Moreover, selective b 2 -adrenoceptor activation was found to produce a stimulation of the L-type Ca 2+ channel current (I Ca ) in guinea-pig atrial myocytes (Iijima & Taira, 1989) , and in rat (Xiao & Lakatta, 1993; Xiao et al., 1994; Cerbai et al., 1995) , guinea-pig (Wang & Pelzer, 1995 ; but see Iijima & Taira, 1989) and dog ventricular myocytes (Altschuld et al., 1995) . When compared to the eect produced by non-selective b-adrenoceptor agonists such as isoprenaline, the b 2 -response may represent 25 ± 100% of the isoprenaline response (Xiao & Lakatta, 1993; Altschuld et al., 1995) . This suggests that the two receptors may dier in their signalling cascade (Lemoine & Kaumann, 1991; Borea et al., 1992; Xiao & Lakatta, 1993; Xiao et al., 1994; Kuznetsov et al., 1995 ; but see Skeberdis et al., 1996) or in the post-receptor ampli®cation mechanisms Bristow et al., 1989; Green et al., 1992; Levy et al., 1993) .
Unlike in the mammalian heart, the b-adrenoceptor population in the frog heart is composed of a majority (& 80%) of b 2 -receptors (Stene-Larsen & Helle, 1978; Hancock et al., 1979; Port et al., 1992; Hieble & Ruolo, 1991) . Thus, one may question the functional role of b 1 -adrenoceptors in this preparation and their contribution to the sympathetic control of heart function. For this reason, we have undertaken a pharmacological characterization of the b-adrenoceptor regulation of I Ca in whole-cell patch-clamped single frog ventricular myocytes. Most particularly, we quanti®ed the contribution of b 1 -and b 2 -receptor subtypes in the stimulating eect of the non-selective b-adrenoceptor agonist isoprenaline on I Ca , by use of, respectively, metoprolol and ICI 118551 as selective antagonists of b 1 -and b 2 -receptors (Bilski et al., 1983; Bylund et al., 1994) . We also investigated the eect of selective b 1 -and b 2 -receptor activation on I Ca by use of, respectively, dobutamine and salbutamol as selective agonists of these receptors (Bylund et al., 1994) . Finally, we examined the eect of xamoterol, a partial b 1 -adrenoceptor agonist (Brodde, 1991; Bylund et al., 1994) on I Ca . All our results converge towards the participation of a single population of receptors in the badrenoceptor-mediated regulation of I Ca in frog ventricular myocytes. These receptors essentially resemble the pharmacologically de®ned b 2 -adrenoceptors of mammalian preparations.
A preliminary account of this work was presented at the 41 st Annual Meeting of the Biophysical Society, New Orleans, U.S.A., March 1997 (Skeberdis et al., 1997) .
Methods
The 
Cell dissociation
Ventricular cells were enzymatically dispersed from frog (Rana esculenta) heart, by a combination of collagenase and trypsin as described by Fischmeister & Hartzell (1986) . Frogs were decapitated and double pithed. The isolated cells were stored in storage Ringer solution, and kept at 48C until use (2 ± 48 h following dissociation).
Electrophysiological experiments
The whole-cell con®guration of the patch-clamp technique was used to record the high-threshold calcium current (I Ca ) on Ca 2+ -tolerant frog ventricular myocytes. In the routine protocols the cells were depolarized every 8 s from a holding potential of 780 vV to 0 mV for 200 ms. Application of tetrodotoxin (0.3 mM) was used to eliminate fast sodium currents. K + currents were blocked by replacing all K + ions with intracellular and extracellular Cs + . Voltage-clamp protocols were generated by a challenger/09-VM programmable function generator (Kinetic Software, Atlanta, GA). The cells were voltage-clamped by use of a patch-clamp ampli®er (model RK-400; Bio-Logic, Claix, France). Currents were sampled at a frequency of 10 kHz by a 16-bit analogue-to-digital converter (PCL816, Advantech France, Levallois Perret, France) connected to a PC compatible 486/66 micro computer.
Control or drug-containing solutions were applied to the exterior of the cell by placing the cell at the opening of 300 mm inner diameter capillary tubings¯owing at a rate of & 50 ml min 7 1 (Fischmeister & Hartzell, 1986) . Changes in extracellular solutions were automatically achieved by a rapid solution changer (RSC100, Bio-Logic, Claix, France). All experiments were done at room temperature (19 ± 258C), and the temperature did not change by more than 18C in a given experiment.
Data analysis
The maximal amplitude of whole-cell I Ca was measured as previously described (Fischmeister & Hartzell, 1986; Argibay et al., 1988) . Currents were not compensated for capacitive and leak currents. On-line analysis of the recordings was made possible by programming a PC-compatible 486/66 microcomputer in Assembling language (Borland, U.S.A.) to determine, for each membrane depolarization, peak and steady-state current values (Fischmeister & Hartzell, 1986 . Antagonist potency was determined by Schild regression (Kenakin, 1993) . The logarithms of dose-ratios minus 1, i.e. log(EC 50 x /EC 50 0 71), were plotted as a function of the logarithms of molar concentrations of the antagonist, i.e. log [X] , and ®t to a straight line by use of a least-means squares regression analysis. The Schild coecient was determined from the slope of the line. The Schild coecient was considered to be equal to unity if the slope was within a 95% con®dence limit range of 0.9 ± 1.2 (Kenakin, 1993 
Materials
For the preparation of frog ventricular myocytes, the ionic composition of Ca 2+ -free Ringer solution was (mM): NaCl 88.4, KCl 2.5, NaHCO 3 23.8, NaH 2 PO 4 0.6, MgCl 2 1.8, creatine 5, D-glucose 10 and 1 mg ml 71 fatty acid-free bovine serum albumin, 50 i u ml 71 penicillin, 50 mg ml 71 streptomycin; pH 7.4 maintained with 95% O 2 , 5% CO 2 . Storage Ringer solution was Ca 2+ -free Ringer solution to which was added 0.9 mM CaCl 2 and 10 ml ml 71 non-essential and essential amino acid and vitamin solution (MEM 1006). Dissociation medium was composed of Ca 2+ -free Ringer solution to which was added 0.2 mg ml 71 trypsin type XIII (Sigma, St. Louis, U.S.A.), 0.14 mg ml 71 collagenase (Yakult, Tokyo, Japan), and 10 ml ml 71 M199 medium (Sigma). For electrophysiology, the control external solution contained (in mM): NaCl 107, HEPES 10, CsCl 20, NaHCO 3 4, NaH 2 PO 4 0.8, MgCl 2 1.8, CaCl 2 1.8, D-glucose 5, sodium pyruvate 5 and tetrodotoxin 3610 74 , pH 7.4 adjusted with NaOH. Patch electrodes (0.6 ± 2.0 MO) were ®lled with control internal solution which contained (mM): CsCl 119.8, EGTA (acid form) 5, MgCl 2 4, creatine phosphate disodium salt 5, Na 2 ATP 3.1, Na 2 GTP 0.42, CaCl 2 (pCa 8.5) 0.062 and HEPES 10; pH 7.1 adjusted with CsOH.
Tetrodotoxin was from Latoxan (Rosans, France). The badrenoceptor agonists and antagonists used were: isoprenaline (Sigma), salbutamol (Sigma), xamoterol (Tocris Cookson, Bristol, U.K.), dobutamine (Tocris Cookson), ICI 118551 (erythro-1 -(7 -methylindan-4-yloxy)-3-isopropylamino-butan-2-ol; Tocris Cookson), and metoprolol (ICN Biomedicals Inc., Aurora, Ohio, U.S.A.). All other drugs were from Sigma. Salbutamol was solubilized in ethanol and all other b-adrenoceptor compounds were dissolved in distilled water. Each day, fresh 1 ± 10 mM stock solutions were prepared and stored at 48C. Immediately before being applied to the cell, the drug was dissolved at the desired ®nal concentration in control external solution, i.e. only fresh solutions were tested. In the case of salbutamol, an appropriate amount of ethanol was added to each solution so that the same ethanol concentration as that present in the solution containing the highest concentration of the drug was present in all solutions tested.
Results
Regulation of I Ca by the non-selective b-adrenoceptor agonist isoprenaline Figure 1a shows a typical experiment with isoprenaline as a non-selective b-adrenoceptor agonist to stimulate I Ca in a frog ventricular myocyte. I Ca was measured every 8 s by depolarizing the cell over a period of 200 ms to 0 mV from a holding potential of780 mV. As shown earlier (Fischmeister & Hartzell, 1986; Hartzell et al., 1991) , isoprenaline produced a dosedependent increase in I Ca . A cumulative dose-response curve for the eect of isoprenaline on I Ca is presented in Figure 1c (&). The data are normalized to the maximal stimulation of I Ca (E max ) which was derived from the ®t of the experimental points to the Michaelis equation (see Methods). Thus, isoprenaline increased I Ca with an EC 50 value of 20.0 nM and E max was 597+105% (n=9).
To examine the participation of b 2 -adrenoceptors in the stimulating eect of isoprenaline on I Ca , the same type of experiment was repeated in the presence of dierent concentrations of ICI 118551, a selective b 2 -adrenoceptor antagonist. As shown in the typical experiment of Figure 1b , ICI 118551 (used at 100 nM in this experiment) was applied ®rst to the myocyte which was then exposed to increasing concentrations of isoprenaline. ICI 118551 alone had no eect on I Ca at any of the concentrations used (1 nM to 1 mM, data not shown). However, in the presence of the drug, larger concentrations of isoprenaline were required to stimulate I Ca (Figure 1b, c) . The mean data points in Figure  1c show the response of I Ca to isoprenaline in the presence of 1 nM, 10 nM, 100 nM and 1 mM ICI 118551. The doseresponse curve for the response of I Ca to isoprenaline was progressively shifted to higher concentrations of the agonist when increasing concentrations of the b 2 -antagonist were used. A Schild regression analysis (see Methods) of the ®ve curves presented in Figure 1c allowed us to determine a Schild coecient close to 1 (1.08) and a K B of 3.80+0.90 nM (n=4) for the inhibitory eect of ICI 118551 on the response of I Ca to isoprenaline. This suggests that, in the range of concentrations used (1 nM to 100 mM), isoprenaline activates I Ca through a single population of receptors which bind ICI 118551 in the low nanomolar range of concentrations.
We then examined the participation of b 1 -adrenoceptors in the stimulating eect of isoprenaline on I Ca . Thus, the same type of experiment as above was repeated in the presence of dierent concentrations of metoprolol, a selective b 1 -adrenoceptor antagonist. As shown in the typical experiment of Figure 2a , a frog myocyte was exposed at ®rst to metoprolol (used at 10 mM in this experiment) and subsequently to increasing concentrations of isoprenaline in the presence of metoprolol. Metoprolol alone had no eect on I Ca at any of the concentrations used (10 nM to 10 mM, data not shown). However, in the presence of the drug, larger concentrations of isoprenaline were required to stimulate I Ca (e.g. compare Figure 1a and 2a) . The mean data points in Figure 2b show the response of I Ca to isoprenaline alone (&, taken from Figure 1c ) or in the presence of 10 nM, 100 nM, 1 mM and 10 mM metoprolol. The dose-response curve for the response of I Ca to isoprenaline was progressively shifted to higher concentrations of the agonist when increasing concentrations of the b 1 -antagonist were used. A competition curve analysis of the ®ve curves of Figure 2b allowed us to determine a Schild coecient close to 1 (1.06) and a K B of 207+51.9 nM (n=3) for the inhibitory eect of metoprolol on the response of I Ca to isoprenaline. This suggests again that isoprenaline activates I Ca through a single population of receptors. These receptors are sensitive to metoprolol in the high nanomolar range of concentrations.
Regulation of I Ca by the selective b 2 -adrenoceptor agonist salbutamol
We have shown earlier that zinterol and salbutamol, two selective b 2 -adrenoceptor agonists, stimulate I Ca in frog ventricular myocytes and produce a similar maximal eect as isoprenaline (Skeberdis et al., 1996) . We have now characterized in more detail the response of I Ca to salbutamol. As shown in the typical experiment of Figure 3a , salbutamol produced a dose-dependent increase in I Ca . A cumulative dose-response curve for the eect of salbutamol on I Ca is presented in Figure  3c (&). Salbutamol increased I Ca with an EC 50 value of 290 nM and E max was 512+69% (n=6). To examine the participation of b 2 -and b 1 -adrenoceptors in the stimulating eect of salbutamol on I Ca , the same type of experiment was repeated in the presence of dierent concentrations of ICI 118551 ( Figure 3b and c) or metoprolol ( Figure 4 ). As shown in the typical experiments of Figure 3b and Figure 4a , ICI 118551 (used at 10 nM in Figure 3b ) and metoprolol (used at 0.1 mM in Figure  4a ) reduced the sensitivity of I Ca to salbutamol, since larger concentrations of the drug were required to stimulate I Ca . The mean data points in Figure 3c show the response of I Ca to salbutamol in the presence of 1 nM, 10 nM and 100 nM ICI [Isoprenaline] (µM) 0 pA -300 100 ms Figure 2 Eect of isoprenaline and metoprolol on I Ca . (a) A frog ventricular myocyte was initially superfused with control external solution in the presence of 10 mM metoprolol. During the periods indicated, the cell was successively exposed to four increasing concentrations of isoprenaline (0.1, 1, 10 and 100 mM). The current traces shown in the inset were recorded at the times indicated by the corresponding letters on the main graph. (b) Concentration-response curve for the stimulating eect of isoprenaline on I Ca. The eects of increasing concentrations of isoprenaline on I Ca were obtained in several experiments performed in the absence of metoprolol (Control, same data as in Figure 1c ) or in the presence of 100 nM, 1 mM or 10 mM metoprolol (as in (a)). The points show the mean and vertical lines s.e.mean of the number of cells indicated. EC 50 and E max values were: 20.0 nM and 597% in control; 34.9 nM and 287% with 100 nM metoprolol; 85.1 nM and 240% with 1 mM metoprolol; 1.13 mM and 715% with 10 mM metoprolol. The data were normalized to E max and are presented as percentage of the maximal response to isoprenaline. 118551. The mean data points in Figure 4b show the response of I Ca to salbutamol alone (&, taken from Figure 3c ) or in the presence of 100 nM, 1 mM and 10 mM metoprolol. It appears that the dose-response curve for the response of I Ca to salbutamol was progressively shifted to higher concentrations of the b 2 -agonist when increasing concentrations of ICI 118551 (Figure 3c ) or metoprolol ( Figure 4b ) were used. A Schild regression analysis (see Methods) of the curves in Figures 3c and 4b allowed us to determine Schild coecients close to 1 (1.12 in Figure 3c , 1.02 in Figure 4b ) and K B values of 1.77+0.28 nM (n=3) for the inhibitory eect of ICI 118551 and 456+57.8 nM (n=3) for the inhibitory eect of metoprolol on the response of I Ca to salbutamol. This suggests that, in the range of concentrations used (10 nM to 100 mM), salbutamol activates I Ca through a single population of receptors which bind ICI 118551 in the low nanomolar range of concentrations and metoprolol in the high nanomolar range of concentrations.
Regulation of I Ca by the selective b 1 -adrenoceptor agonist dobutamine
The same strategy was applied to examine the eect of a selective b 1 -adrenoceptor agonist, dobutamine, on I Ca in frog ventricular myocytes. As shown in the experiment of Figure   5a , dobutamine produced a dose-dependent increase in I Ca . A cumulative dose-response curve for the eect of dobutamine on I Ca is presented in Figure 5c (&). Dobutamine increased I Ca with an EC 50 value of 2.4 mM and E max was 265+47% (n=7). However, we found that increasing the concentration of dobutamine above 100 mM produced severe inhibitory effects on I Ca and a complete block of the current appeared at a concentration of 1 mM. Thus, in the following, only the ef- Figure 3c ) or in the presence of 0.1 mM (as in (a)), 1 mM or 10 mM metoprolol. The points show the mean and vertical lines s.e.mean of the number of cells indicated. EC 50 and E max values were: 290 nM and 512% in control; 367 nM and 631% with 0.1 mM metoprolol; 800 nM and 802% with 1 mM metoprolol; 7.13 mM and 532% with 10 mM metoprolol. The data were normalized to E max and are presented as percentage of the maximal response to salbutamol.
[Dobutamine] (µM) 
b-Adrenoceptors and Ca current in frog heart
fects of lower concentrations of dobutamine (4100 mM) were investigated. To examine the participation of b 2 -and b 1 -adrenoceptors in the stimulating eect of dobutamine on I Ca , the same type of experiment was repeated in the presence of dierent concentrations of ICI 118551 (Figure 5b and c) or metoprolol ( Figure 6 ). As shown in the typical experiments of Figure 5b and Figure 6a , ICI 118551 (used at 1 nM in Figure  5b ) and metoprolol (used at 0.1 mM in Figure 6a ) reduced the sensitivity of I Ca to dobutamine, since larger concentrations of the drug were required to stimulate I Ca . The mean data points in Figure 5c show the response of I Ca to dobutamine in the presence of 1 nM, 3 nM and 10 nM ICI 118551. The mean data points in Figure 6b show the response of I Ca to dobutamine alone (&, taken from Figure 5c ) or in the presence of 100 nM, 1 mM and 10 mM metoprolol. It appears that the dose-response curve for the response of I Ca to dobutamine was progressively shifted to higher concentrations of the b 1 -agonist when increasing concentrations of ICI 118551 ( Figure  5c [Dobutamine] (µM) Figure 6 Eect of dobutamine and metoprolol on I Ca. (a) A frog ventricular myocyte was initially superfused with control external solution in the presence of 0.1 mM metoprolol. During the periods indicated, the cell was successively exposed to four increasing concentrations of dobutamine (0.1, 1, 10 and 100 mM). The current traces shown in the inset were recorded at the times indicated by the corresponding letters on the main graph. (b) Concentration-response curve for the stimulating eect of dobutamine on I Ca . The eect of increasing concentrations of dobutamine on I Ca were obtained in several experiments performed in the absence of metoprolol (Control, same data as in Figure 5c ) or in the presence of 100 nM (as in (a)), 1 mM or 10 mM metoprolol. The points show the mean and vertical lines s.e.mean of the number of cells indicated. EC 50 and E max values were: 2.40 mM and 265% in control; 2.93 mM and 260% with 100 nM metoprolol; 6.54 mM and 91% with 1 mM metoprolol; 33.7 mM and 754% with 10 mM metoprolol. The data were normalized to E max and are presented as percentage of the maximal response to dobutamine. Figure 7 Eect of xamoterol and isoprenaline on I Ca. (a) A frog ventricular myocyte was initially superfused with control external solution. During the periods indicated, the cell was successively exposed to seven increasing concentrations of xamoterol (0.001, 0.01, 0.1, 1, 10, 100 and 1000 mM). (b) A frog ventricular myocyte was initially superfused with control external solution. During the periods indicated, the cell was successively exposed 10 mM xamoterol and, then, to four increasing concentrations of isoprenaline (0.1, 1, 10 and 100 mM). The current traces shown in the inset of (b) were recorded at the times indicated by the corresponding letters on the main graphs. (c) Concentration-response curve for the stimulating eect of isoprenaline on I Ca . The eect of increasing concentrations of isoprenaline on I Ca were obtained in several experiments performed in the absence of xamoterol (Control, same data as in Figure 1c ) or in the presence of 0.1 mM, 1 mM or 10 mM xamoterol (as in (b)). The points show the mean and vertical lines s.e.mean of the number of cells indicated. EC 50 and E max values were: 20.0 nM and 597% in control; 60.0 nM and 1098% with 0.1 mM xamoterol; 240 nM and 730% with 1 mM xamoterol; 5.51 mM and 905% with 10 mM xamoterol. The data were normalized to E max and are presented as percentage of the maximal response to isoprenaline.
Regulation of I Ca by the b 1 -adrenoceptor partial agonist xamoterol
We also examined the eects of a b 1 -adrenoceptor partial agonist, xamoterol, on I Ca in frog ventricular myocytes. Surprisingly, xamoterol (from 1 nM to 1 mM), unlike dobutamine ( Figure 5 ), did not produce any stimulating eect on I Ca (Figure 7a ). On the contrary, xamoterol antagonized the stimulating eect of the three other b-adrenoceptor agonists tested. Indeed, the individual experiments in Figures 7b, 8a and 9a show that the presence of xamoterol (10 mM in Figure  7b , 0.1 mM in Figure 8a , 0.1 mM in Figure 9a ) reduced the sensitivity of I Ca to isoprenaline (compare Figures 7b and 1a) , dobutamine (compare Figures 8a and 5a ) and salbutamol (compare Figures 9a and 3a) . The mean data points in Figure  7c show the response of I Ca to isoprenaline alone (&, taken from Figure 1c ) or in the presence of 100 nM, 1 mM and 10 mM xamoterol. The mean data points in Figure 8b show the response of I Ca to dobutamine alone (&, taken from Figure 5c ) or in the presence of 100 nM and 300 nM xamoterol. The mean data points in Figure 9b show the response of I Ca to salbutamol alone (&, taken from Figure 3c ) or in the presence of 100 nM, 1 mM and 10 mM xamoterol. In all cases, the doseresponse curves for the response of I Ca to a b-adrenoceptor agonist were progressively shifted to higher concentrations of the agonist when increasing concentrations of xamoterol were used. A Schild regression analysis (see Methods) of the curves in Figures 7c and 9b allowed us to determine Schild coecients of, respectively, 0.92 and 0.99, and K B values of 59.1+16.4 (n=3) and 64.4+7.84 nM (n=3), for the inhibitory eect of xamoterol on the response of I Ca to isoprenaline (Figure 7c ) and salbutamol (Figure 9b ). Since dobutamine produced deleterious eects on I Ca at concentrations 4100 mM, we were unable to obtain sucient data to perform a satisfactory Schild regression analysis with dobutamine in the presence of high concentrations of xamoterol (Figure 8b ). However, if we assume that there is competitive interaction between dobutamine and xamoterol (i.e. a Schild coecient of 1), then the dose-response curves of Figure 8b lead to a K B value of 57.7+13.6 nM (n=2) for the inhibitory eect of xamoterol on the response of I Ca to dobutamine. Since this value is very Figure 5c ). or in the presence of 0.1 mM (as in (a)) or 0.3 mM xamoterol. The points show the mean and vertical lines s.e.mean of the number of cells indicated. EC 50 and E max values were: 2.40 mM and 265% in control; 5.52 mM and 191% with 0.1 mM xamoterol; 21.2 mM and 211% with 0.3 mM xamoterol. The data were normalized to E max and are presented as percentage of the maximal response to dobutamine. 
Discussion
In the present study, we examined the eect of isoprenaline and several selective b 1 -and b 2 -adrenoceptor agonists and antagonists on the L-type Ca 2+ current (I Ca ) in frog ventricular myocytes. With the exception of xamoterol, which is a partial b 1 -agonist, all the agonists used (isoprenaline (non-selective), salbutamol (b 2 -selective), dobutamine (b 1 -selective)) produced a dose-dependent stimulation of I Ca . In a previous study of ours, we have shown that zinterol, another b 2 -adrenoceptor agonist, also stimulates frog I Ca in a dose-dependent manner (Skeberdis et al., 1996) . While salbutamol and zinterol (Skeberdis et al., 1996) increased I Ca with a similar ecacy to isoprenaline, the ecacy of dobutamine was only half that of isoprenaline. EC 50 values were calculated from the dose-response curves for the stimulating eects of the agonists on I Ca which allowed us to determine the potency rank order for these agonists: zinterol (2.2 nM, Skeberdis et al., 1996) 4isoprenaline (20 nM)4salbutamol (290 nM)4dobutamine (2.4 mM)44 xamoterol. Whatever the agonist used to stimulate I Ca , their eect was antagonized by ICI 118551 (b 2 -antagonist) and metoprolol (b 1 -antagonist), as well as by xamoterol. Competition curve analysis by use of the Schild equation yielded a Schild coecient of 1 (0.9 ± 1.2) in all experimental conditions. This suggests that all the b-adrenoceptor agonists and antagonists tested competed on a single population of receptors. Equilibrium dissociation constants (K B ) for the receptor-antagonist complex were calculated from the Schild equation in each experimental condition. This allowed us to determine a rank order of potency for the dierent antagonists: ICI 118551 (2 ± 4 nM)4xamoterol (60 nM)4metoprolol (200 ± 600 nM). We conclude that a single population of receptors is involved in the b-adrenoceptor regulation of I Ca in frog ventricular myocytes. The pharmacological pro®les obtained indicate that this population of receptors ®ts the criteria set for the b 2 -adrenoceptor subtype in mammalian tissue.
Although initial competitive binding studies concluded that b 2 -adrenoceptors are not present in puri®ed ventricular myocytes from mammalian hearts (Lau et al., 1980; Buxton & Brunton, 1985; Freissmuth et al., 1986) , more recent studies have clearly established the presence of these receptors in ventricular myocytes from several mammals, such as rats (Kuznetsov et al., 1995; Cerbai et al., 1995) , dogs (Murphree & Satz, 1988) , baboons (Cui et al., 1996) and man (del Monte et al., 1993) . However, the b 1 /b 2 ratio may vary somewhat from one study to the other in a given animal species (e.g. 80/ 20 to 92/8 in rat myocytes: Cerbai et al., 1995; Kuznetsov et al., 1995; Cui et al., 1996) and from one species to the other (e.g. 85/15 in dog: Murphree & Satz, 1988 ; 59/41 in baboon: Cui et al., 1996) . The b 1 /b 2 ratio may also vary depending on the pathophysiological state (Brodde, 1993; Ihl-Vahl et al., 1996) , the age (White et al., 1994; Cerbai et al., 1995) or the developmental stage (Kuznetsov et al., 1995 ; for reviews, see Stiles et al., 1984; Brodde, 1991; Hieble & Ruolo, 1991 and references therein) . Finally, the proportion of b 2 -adrenoceptors was shown to be somewhat larger in atrial compared to ventricular tissues (Carlsson et al., 1977; Hedberg et al., 1980; Molenaar & Summers, 1987) , and more so in human where b 2 -adrenoceptors may account for 35 ± 50% of the total number of b-receptors Brodde, 1991; Hieble & Ruolo, 1991) . The latter ®nding may explain why b 2 -adrenoceptor agonists exert preferentially positive chronotropic rather than inotropic eects in man (Brodde, 1991) .
Unlike in mammals, the b-adrenoceptors in the frog heart are composed of a majority of b 2 -subtype. Radioligand binding experiments and competition curve analysis in frog myocardial membrane preparations have shown that the proportion of b 2 -receptors may vary from 50% to 100% of the total population of b-receptors depending on the speci®c antagonist used to displace the radiolabelled ligand and the individual cell preparation (Hancock et al., 1979; Port et al., 1992) . Measurements of force and rate of spontaneous contractions in the isolated heart (Lands et al., 1969) or in isolated auricles (Stene-Larsen & Helle, 1978) of the frog have shown that the inotropic and chronotropic responses to various sympathomimetic amines are essentially mediated by b 2 -adrenoceptors. This suggests that, although present in the sarcolemmal membrane, b 1 -adrenoceptors may not be functionally coupled to the eectors involved in the contractile and electrical activities of the frog heart. Since the L-type Ca 2+ channel current (I Ca ) is one of the main actors in the excitation-contraction coupling of the frog heart, it was of interest to examine how this current is regulated by the two populations of b-adrenoceptors receptors.
Selective agonists of b 2 -adrenoceptors were shown earlier to increase I Ca in mammalian cardiac myocytes, such as guineapig atrial myocytes (Iijima & Taira, 1989) , rat (Xiao & Lakatta, 1993; Cerbai et al., 1995) , dog (Altschuld et al., 1995) and guinea-pig ventricular myocytes (Wang & Pelzer, 1995 ; but see Iijima & Taira, 1989) . The maximal stimulating eect of these agonists on I Ca varied from 30% in guinea-pig (Wang & Pelzer, 1995) to 100% in rat ventricular myocytes (Xiao & Lakatta, 1993) of the eect of isoprenaline. In frog cardiomyocytes, we found that selective activation of b 2 -adrenoceptors with salbutamol (this study) or with zinterol (Skeberdis et al., 1996) accounted for 100% of the isoprenaline response in frog ventricular myocytes. By comparison, the maximal stimulant eect of the b 1 -agonist dobutamine on I Ca was only about half that of isoprenaline, while xamoterol had no stimulant eect at all. Thus, the agonists acting more selectively on the b 2 -adrenoceptors (zinterol, salbutamol) had a higher potency and ecacy in stimulating frog I Ca than the agonists acting on the b 1 -receptors (dobutamine, xamoterol). Moreover, the stimulating eect of dobutamine on I Ca was probably mediated by activation of b 2 -, and not b 1 -, receptors. Indeed, dobutamine increased I Ca with an EC 50 of 2.4 mM, which is two orders of magnitude higher than the concentration at which it binds selectively to mammalian b 1 -receptors (Brodde, 1991) . Moreover, the stimulating eect of dobutamine on I Ca was strongly antagonized by ICI 118551 (K B =2.8 nM) while it was only weakly antagonized by metoprolol (K B =609 nM). While at a concentration of 2.8 nM ICI 118551 remains a highly selective antagonist of b 2 -receptors (Bylund et al., 1994) , metoprolol is not selective for b 1 -receptors anymore when its concentration approaches the micromolar range (Bylund et al., 1994) . Since ICI 118551 and metoprolol antagonized the stimulant eects of isoprenaline, dobutamine and salbutamol on I Ca with the same K B values (2 ± 4 nM for ICI 118551, 200 ± 600 nM for metoprolol) and the same Schild coecient (equal to 1), it is likely that these agonists and antagonists produced their eects by binding exclusively to b 2 -adrenoceptors. However, the frog b 2 -receptor may dier somewhat from its mammalian counterpart since salbutamol increased I Ca with an EC 50 of 290 nM, which was about 10 fold higher than the concentration required to activate b 2 -receptors in mammalian preparations (Bylund et al., 1994) . On the contrary, the frog cardiac b 2 -receptor appears to be about 50 times more sensitive to zinterol than the mammalian cardiac b 2 -receptor (EC 50 =2.2 nM in frog myocytes, Skeberdis et al., 1996 ; EC 50 =1 mM in rat myocytes, Xiao & Lakatta, 1993) . Another peculiarity of the frog cardiac b 2 -receptor is its relatively high sensitivity to xamoterol. While xamoterol alone had no eect on I Ca , this partial b 1 -agonist antagonized the stimulant eect of isoprenaline, dobutamine and salbutamol with a similar K B value (& 60 nM) independently of which agonist was used to stimulate I Ca . The Schild coecient was equal to 1 in all cases, demonstrating that xamoterol competed with the agonist on a single population of receptors. Thus, xamoterol is an antagonist of frog b 2 -receptors and binds to these receptors with an anity which is comparable to that at which it binds to mammalian b 1 -receptors (Brodde, 1991; Bylund et al., 1994) .
The major ®nding of our study is that the b-adrenoceptor regulation of I Ca in frog cardiac myocytes is exclusively mediated by b 2 -adrenoceptors. This observation is consistent with earlier functional data obtained on whole heart (Lands et al., 1969) or multicellular cardiac preparations of the frog (Stene-Larsen & Helle, 1978) . This ®nding is also consistent with the fact that the sympathetic nerves carry adrenaline in the frog (Loewi, 1936) and the b 2 -receptor is, by de®nition, aǹ adrenaline receptor' (Stene-Larsen & Helle, 1978) . However, there is evidence for the presence of b 1 -receptors in frog cardiac myocytes (Hancock et al., 1979; Port et al., 1992) , and their relative proportion is comparable to that of b 2 -receptors in mammalian cardiac myocytes (Hieble & Ruolo, 1991) . Interestingly, b 2 -receptors have been shown to be more tightly coupled to the adenylyl cyclase than b 1 -receptors Bristow et al., 1989; Green et al., 1992; Levy et al., 1993) . This may explain why b 2 -adrenoceptors, although present in a minority in mammalian cardiac myocytes, are eciently coupled to I Ca and contraction in these preparations (Xiao & Lakatta, 1993; Xiao et al., 1994; Altschuld et al., 1995; Kuznetsov et al., 1995; Skeberdis et al., 1996) . In frog myocytes where they are present in a majority, the coupling of b 2 -receptors to adenylyl cyclase may overwhelm that of b 1 -receptors and nullify their contribution to the stimulation of I Ca . Alternatively, b 2 -receptors may lead to an elevation of adenosine 3':5'-cyclic monophosphate (cyclic AMP) in a compartment more eciently coupled to L-type Ca 2+ channels than b 1 -receptors (JurevicÏ ius Skeberdis et al., 1996) . Further experiments are needed to examine these hypotheses and to determine the function of b 1 -receptors in the frog heart.
